Showing 721 - 740 results of 63,149 for search '(( 50 ((((ppm decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 2 e decrease ))', query time: 1.07s Refine Results
  1. 721
  2. 722
  3. 723
  4. 724
  5. 725
  6. 726
  7. 727

    S1 File - by Chantelle M. de Vet (16535257)

    Published 2024
    “…The student’s RV-GLS consistency was poor during the first 25 measurements, moderate-to good during the second 25 measurements and again poor-to-moderate during the final 50 measurements. Repeated measurements analysis showed a significant decrease in variability of the LV- and RV-GLS score differences between the expert and trainees over time (<i>p</i><sub>adj</sub><0.001), which was not significantly different between trainees. …”
  8. 728
  9. 729
  10. 730
  11. 731

    Substitution of a lysine residue at position 8 of two model 9mer H2-K<sup>b</sup> epitope precursors leads to a marked decrease of N-terminus trimming by ERAP1 <i>in vitro</i>. by Irini Evnouchidou (375919)

    Published 2013
    “…<p><i>Panels </i><i>A</i><i> and </i><i>B</i>, peptides LSIINFEKL and the variant LSIINFEAL (both at 50 µM) were incubated with 7.8 nM of ERAP1 for 1 hr at 37°C and the products analyzed by RP-HPLC. …”
  12. 732
  13. 733
  14. 734
  15. 735
  16. 736

    Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

    Published 2011
    “…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”
  17. 737
  18. 738
  19. 739
  20. 740

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

    Published 2021
    “…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”